Protect II, A Prospective, Multicenter Randomized Controlled Trial

Stopped early · Phase 3

Conditions studied: Coronary Artery Disease

In brief

The IMPELLA® 2.5 System will be superior to Intra Aortic Balloon Pump in preventing the composite rate of major adverse events during and after the PCI procedure.

Key facts

Study ID
NCT00562016
Run by
Abiomed Inc.
People needed
452
Starts
2007-10-01
Expected to finish
2011-09-01
Last updated by the study team
2011-03-21

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.